The House Judiciary Subcommittee on Competition held a hearing examining the proposed merger between pharmacy benefit management companies Express Scripts and Medco Health Solutions. Among the issues they addressed were antitrust concerns about the merger, prescription drug costs, and the potential impact on community pharmacies. The proposed merger would create a company involved in about a third of the prescription drug transactions in the U.S.